Thank you, Mr. Chair.
Earlier in the meeting, in the first panel, we heard some testimony regarding the PMPRB's being asked to appear.
I just want to correct the record while I have a chance. The PMPRB was only invited yesterday. My understanding is that they would be happy to appear. I think it is important, given the testimony we heard today in the first panel, that we invite the PMPRB.
That said, I move that the Standing Committee on Health hold an additional meeting on the Patented Medicine Prices Review Board guidelines—as we were initially scheduled to do—in place of one of the meetings to be scheduled during the regularly scheduled meeting slots prior to the end of day on June 21, 2021; that the clerk invite the PMPRB to appear as a witness; that the meeting take place for two hours; and that, in addition to the PMPRB witness, each party be allowed to invite one witness for this meeting on the Patented Medicine Prices Review Board's guidelines.